Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	IgG receptor activity	FCGR2C FCGR2A FCGR2B	3.83e-06	7	97	3	GO:0019770
GeneOntologyMolecularFunction	IgG binding	FCGR2C FCGR2A FCGR2B	1.78e-05	11	97	3	GO:0019864
GeneOntologyMolecularFunction	immunoglobulin receptor activity	FCGR2C FCGR2A FCGR2B	3.89e-05	14	97	3	GO:0019763
GeneOntologyMolecularFunction	low-affinity IgG receptor activity	FCGR2A FCGR2B	1.39e-04	4	97	2	GO:0019772
GeneOntologyMolecularFunction	alpha-1,4-glucosidase activity	MGAM SI	2.31e-04	5	97	2	GO:0004558
GeneOntologyMolecularFunction	transcription coregulator activity	TOB2 MAGED1 NUP98 ZMIZ1 KMT2E TRRAP HDAC7 KMT2C TRIM62 CAMTA1	4.03e-04	562	97	10	GO:0003712
GeneOntologyMolecularFunction	alpha-glucosidase activity	MGAM SI	4.83e-04	7	97	2	GO:0090599
GeneOntologyMolecularFunction	transcription coactivator activity	MAGED1 NUP98 ZMIZ1 KMT2E TRRAP KMT2C TRIM62	6.92e-04	303	97	7	GO:0003713
GeneOntologyMolecularFunction	immunoglobulin binding	FCGR2C FCGR2A FCGR2B	7.06e-04	36	97	3	GO:0019865
GeneOntologyMolecularFunction	histone H3 methyltransferase activity	KMT2E ASH2L KMT2C	1.27e-03	44	97	3	GO:0140938
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TOB2 MAGED1 NUP98 NBN LAMP2 ZMIZ1 KMT2E TRRAP HDAC7 KMT2C SHANK2 G3BP2 TRIM62 CAMTA1	1.41e-03	1160	97	14	GO:0030674
GeneOntologyBiologicalProcess	negative regulation of type I hypersensitivity	FCGR2A FCGR2B	2.19e-05	2	97	2	GO:0001811
GeneOntologyBiologicalProcess	antibody-dependent cellular cytotoxicity	FCGR2C FCGR2A FCGR2B	2.79e-05	13	97	3	GO:0001788
GeneOntologyBiologicalProcess	type IIa hypersensitivity	FCGR2C FCGR2A FCGR2B	4.40e-05	15	97	3	GO:0001794
GeneOntologyBiologicalProcess	type II hypersensitivity	FCGR2C FCGR2A FCGR2B	4.40e-05	15	97	3	GO:0002445
GeneOntologyBiologicalProcess	adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains	IGHV1-45 BACH2 IGHV1-8 IGHV1-3 NBN FCGR2C FCGR2A FCGR2B MTOR KLRD1	6.37e-05	462	97	10	GO:0002460
GeneOntologyBiologicalProcess	immunoglobulin mediated immune response	IGHV1-45 IGHV1-8 IGHV1-3 NBN FCGR2C FCGR2A FCGR2B	1.23e-04	235	97	7	GO:0016064
GeneOntologyBiologicalProcess	disaccharide catabolic process	MGAM SI	1.31e-04	4	97	2	GO:0046352
GeneOntologyBiologicalProcess	negative regulation of hypersensitivity	FCGR2A FCGR2B	1.31e-04	4	97	2	GO:0002884
GeneOntologyBiologicalProcess	B cell mediated immunity	IGHV1-45 IGHV1-8 IGHV1-3 NBN FCGR2C FCGR2A FCGR2B	1.55e-04	244	97	7	GO:0019724
GeneOntologyBiologicalProcess	detection of light stimulus involved in visual perception	SEMA5A PCARE EYS	2.15e-04	25	97	3	GO:0050908
GeneOntologyBiologicalProcess	detection of light stimulus involved in sensory perception	SEMA5A PCARE EYS	2.15e-04	25	97	3	GO:0050962
GeneOntologyBiologicalProcess	hypersensitivity	FCGR2C FCGR2A FCGR2B	2.15e-04	25	97	3	GO:0002524
GeneOntologyBiologicalProcess	regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway	FCGR2A FCGR2B	2.17e-04	5	97	2	GO:1903381
GeneOntologyBiologicalProcess	negative regulation of neutrophil apoptotic process	FCGR2A FCGR2B	2.17e-04	5	97	2	GO:0033030
GeneOntologyCellularComponent	photoreceptor outer segment	MYO5A PCDHB13 PCARE EYS SHANK2 GNAT3	1.38e-05	111	98	6	GO:0001750
GeneOntologyCellularComponent	photoreceptor cell cilium	MYO5A PCDHB13 PCARE EYS SHANK2 GNAT3	4.94e-05	139	98	6	GO:0097733
GeneOntologyCellularComponent	9+0 non-motile cilium	MYO5A PCDHB13 PCARE EYS SHANK2 GNAT3	8.43e-05	153	98	6	GO:0097731
GeneOntologyCellularComponent	non-motile cilium	MYO5A PCDHB13 PCARE EYS SHANK2 GNAT3	3.24e-04	196	98	6	GO:0097730
GeneOntologyCellularComponent	cell body	RASGRF1 MYO5A NTRK1 APOB AQP1 SHANK2 FCGR2A FCGR2B MTOR LTBP1 PARD3 CTSV SEZ6	3.94e-04	929	98	13	GO:0044297
GeneOntologyCellularComponent	histone deacetylase complex	KMT2E TRRAP HDAC7 CDK2AP1	6.88e-04	85	98	4	GO:0000118
GeneOntologyCellularComponent	secretory granule	MGAM MYO5A LAMP2 MORN2 AQP1 FCGR2A SCG3 FGB GNAT3 PLAT LRRC7 CTSV SLC27A2	8.93e-04	1014	98	13	GO:0030141
Domain	Glyco_hydro_31_CS	MGAM SI	1.53e-04	4	95	2	IPR030459
Domain	Gal_mutarotase_N	MGAM SI	1.53e-04	4	95	2	IPR031727
Domain	NtCtMGAM_N	MGAM SI	1.53e-04	4	95	2	PF16863
Domain	DZF	ILF3 ZFR	2.53e-04	5	95	2	SM00572
Domain	GLYCOSYL_HYDROL_F31_2	MGAM SI	2.53e-04	5	95	2	PS00707
Domain	DZF_dom	ILF3 ZFR	2.53e-04	5	95	2	IPR006561
Domain	DZF	ILF3 ZFR	2.53e-04	5	95	2	PF07528
Domain	DZF	ILF3 ZFR	2.53e-04	5	95	2	PS51703
Domain	Glyco_hydro_31_AS	MGAM SI	3.79e-04	6	95	2	IPR030458
Domain	FAT	TRRAP MTOR	3.79e-04	6	95	2	PS51189
Domain	FATC	TRRAP MTOR	3.79e-04	6	95	2	PS51190
Domain	FAT	TRRAP MTOR	3.79e-04	6	95	2	PF02259
Domain	PIK-rel_kinase_FAT	TRRAP MTOR	3.79e-04	6	95	2	IPR003151
Domain	FATC_dom	TRRAP MTOR	3.79e-04	6	95	2	IPR003152
Domain	PIK_FAT	TRRAP MTOR	3.79e-04	6	95	2	IPR014009
Domain	FATC	TRRAP MTOR	3.79e-04	6	95	2	SM01343
Domain	Glyco_hydro_31	MGAM SI	5.29e-04	7	95	2	IPR000322
Domain	Glyco_hydro_31	MGAM SI	5.29e-04	7	95	2	PF01055
Domain	GLYCOSYL_HYDROL_F31_1	MGAM SI	5.29e-04	7	95	2	PS00129
Domain	P_TREFOIL_1	MGAM SI	7.03e-04	8	95	2	PS00025
Domain	Trefoil	MGAM SI	7.03e-04	8	95	2	PF00088
Domain	P_trefoil_CS	MGAM SI	7.03e-04	8	95	2	IPR017957
Domain	P_TREFOIL_2	MGAM SI	9.00e-04	9	95	2	PS51448
Domain	PD	MGAM SI	9.00e-04	9	95	2	SM00018
Domain	-	MGAM SI	1.37e-03	11	95	2	4.10.110.10
Domain	P_trefoil_dom	MGAM SI	1.63e-03	12	95	2	IPR000519
Domain	DUF4599	SPATA31D4 SPATA31D3	1.63e-03	12	95	2	PF15371
Domain	DUF4599	SPATA31D4 SPATA31D3	1.63e-03	12	95	2	IPR027970
Domain	ig	MDGA2 FCGR2A PTPRM FCGR2B CNTN5	2.86e-03	190	95	5	PF00047
Domain	Immunoglobulin	MDGA2 FCGR2A PTPRM FCGR2B CNTN5	2.86e-03	190	95	5	IPR013151
Domain	MAM_1	MDGA2 PTPRM	2.93e-03	16	95	2	PS00740
Domain	-	TRRAP MTOR	2.93e-03	16	95	2	1.10.1070.11
Domain	PI3Kc	TRRAP MTOR	2.93e-03	16	95	2	SM00146
Domain	Gal_mutarotase_SF_dom	MGAM SI	3.31e-03	17	95	2	IPR011013
Domain	MAM	MDGA2 PTPRM	3.31e-03	17	95	2	SM00137
Domain	MAM	MDGA2 PTPRM	3.71e-03	18	95	2	PF00629
Domain	PI3_PI4_kinase	TRRAP MTOR	3.71e-03	18	95	2	PF00454
Domain	MAM_dom	MDGA2 PTPRM	3.71e-03	18	95	2	IPR000998
Domain	PI3_4_KINASE_1	TRRAP MTOR	3.71e-03	18	95	2	PS00915
Domain	PI3_4_KINASE_2	TRRAP MTOR	3.71e-03	18	95	2	PS00916
Domain	PI3/4_kinase_cat_dom	TRRAP MTOR	3.71e-03	18	95	2	IPR000403
Domain	PI3_4_KINASE_3	TRRAP MTOR	3.71e-03	18	95	2	PS50290
Domain	MAM_2	MDGA2 PTPRM	3.71e-03	18	95	2	PS50060
Pubmed	Nonallelic homologous recombination of the FCGR2/3 locus results in copy number variation and novel chimeric FCGR2 genes with aberrant functional expression.	FCGR2C FCGR2A FCGR2B	2.38e-08	3	101	3	26133275
Pubmed	Functional Fcgamma receptor polymorphisms are associated with human allergy.	FCGR2C FCGR2A FCGR2B	2.38e-08	3	101	3	24586589
Pubmed	Protease nexin-1, tPA, and PAI-1 are upregulated in cryoglobulinemic membranoproliferative glomerulonephritis.	FCGR2A FCGR2B PLAT	9.49e-08	4	101	3	18199802
Pubmed	C-Reactive Protein Promotes Diabetic Kidney Disease in db/db Mice via the CD32b-Smad3-mTOR signaling Pathway.	FCGR2A FCGR2B MTOR	2.37e-07	5	101	3	27221338
Pubmed	Copy number variation at the FCGR locus includes FCGR3A, FCGR2C and FCGR3B but not FCGR2A and FCGR2B.	FCGR2C FCGR2A FCGR2B	2.37e-07	5	101	3	19309690
Pubmed	SNPs of Fc-gamma receptor genes and chronic periodontitis.	FCGR2C FCGR2A FCGR2B	2.37e-07	5	101	3	20439936
Pubmed	Copy number, linkage disequilibrium and disease association in the FCGR locus.	FCGR2C FCGR2A FCGR2B	2.37e-07	5	101	3	20508037
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	TOB2 MAGED1 NEDD4L NUP98 MLLT10 KMT2E ZRANB3 ZFR CAMTA1 KPNA3	5.31e-07	430	101	10	35044719
Pubmed	Human transcription factor protein interaction networks.	MAGED1 MYO5A NUP98 NBN ZMIZ1 MLLT10 TEX10 LARP4 TRRAP ASH2L KMT2C G3BP2 MKI67 ZFR CEP152 SENP5	3.60e-06	1429	101	16	35140242
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	NEDD4L DNAJC6 ASH2L USP6 G3BP2 CEP152 CAMTA1 ELOVL6 PARD3 MBD5	3.81e-06	536	101	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	NEDD4L DNAJC6 ASH2L USP6 G3BP2 CEP152 CAMTA1 ELOVL6 PARD3 MBD5	3.94e-06	538	101	10	10512203
Pubmed	Novel genetic loci identified for the pathophysiology of childhood obesity in the Hispanic population.	ILF3 BACH2 SEMA5A MDGA2 MORN2 HDAC7 SHANK2 CNTN5 LRRC7 CEP152 ELOVL6 KPNA3	4.42e-06	814	101	12	23251661
Pubmed	A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal.	ILF3 ZCCHC8 TRRAP ASH2L KMT2C ZFR	4.51e-06	146	101	6	23892456
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	MAGED1 MYO5A ZCCHC8 DNAJC21 NBN LAMP2 TEX10 TRRAP ASH2L KMT2C PAXBP1 SHANK2 CDK2AP1 VANGL1 PARD3 KPNA3	6.47e-06	1497	101	16	31527615
Pubmed	Human FcγRII cytoplasmic domains differentially influence antibody-mediated dengue virus infection.	FCGR2A FCGR2B	8.35e-06	2	101	2	23616574
Pubmed	FcgammaRIIa (CD32) polymorphism and anti-malarial IgG subclass pattern among Fulani and sympatric ethnic groups living in eastern Sudan.	FCGR2A FCGR2B	8.35e-06	2	101	2	19284648
Pubmed	Uptake of human papillomavirus virus-like particles by dendritic cells is mediated by Fcgamma receptors and contributes to acquisition of T cell immunity.	FCGR2A FCGR2B	8.35e-06	2	101	2	17548594
Pubmed	Intraperitoneal Immunization with Cry1Ac Protoxin from Bacillus thuringiensis Provokes Upregulation of Fc-Gamma-II/and Fc-Gamma-III Receptors Associated with IgG in the Intestinal Epithelium of Mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	25904149
Pubmed	Development of self-reactive germinal center B cells and plasma cells in autoimmune Fc gammaRIIB-deficient mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	21078890
Pubmed	FcγRIIB is a T cell checkpoint in antitumor immunity.	FCGR2A FCGR2B	8.35e-06	2	101	2	33616086
Pubmed	Etanercept prevents TNF-α mediated mandibular bone loss in FcγRIIb-/- lupus model.	FCGR2A FCGR2B	8.35e-06	2	101	2	33861790
Pubmed	FcgammaRIIb inhibits allergic lung inflammation in a murine model of allergic asthma.	FCGR2A FCGR2B	8.35e-06	2	101	2	20179765
Pubmed	Respiratory syncytial virus persistence in macrophages upregulates Fcgamma receptors expression.	FCGR2A FCGR2B	8.35e-06	2	101	2	24509813
Pubmed	Antigen-Specific IgG ameliorates allergic airway inflammation via Fcγ receptor IIB on dendritic cells.	FCGR2A FCGR2B	8.35e-06	2	101	2	21477339
Pubmed	Therapeutic inhibition of FcγRIIb signaling targets leukemic stem cells in chronic myeloid leukemia.	FCGR2A FCGR2B	8.35e-06	2	101	2	32684632
Pubmed	Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis.	FCGR2A FCGR2B	8.35e-06	2	101	2	11983693
Pubmed	Acute Kidney Injury Induced Lupus Exacerbation Through the Enhanced Neutrophil Extracellular Traps (and Apoptosis) in Fcgr2b Deficient Lupus Mice With Renal Ischemia Reperfusion Injury.	FCGR2A FCGR2B	8.35e-06	2	101	2	34248948
Pubmed	Negative regulation of c-kit-mediated cell proliferation by Fc gamma RIIB.	FCGR2A FCGR2B	8.35e-06	2	101	2	10201978
Pubmed	Antigen-induced oligomerization of the B cell receptor is an early target of Fc gamma RIIB inhibition.	FCGR2A FCGR2B	8.35e-06	2	101	2	20083655
Pubmed	Human IgG Fc receptor (hFcRII; CD32) exists as multiple isoforms in macrophages, lymphocytes and IgG-transporting placental epithelium.	FCGR2C FCGR2B	8.35e-06	2	101	2	2531080
Pubmed	Genomic organization of mouse Fc gamma receptor genes.	FCGR2A FCGR2B	8.35e-06	2	101	2	2138787
Pubmed	Fc receptors: rubor redux.	FCGR2A FCGR2B	8.35e-06	2	101	2	8069908
Pubmed	Genetic control of T-cell proliferative response in mice linked to chromosomes 11 and 15.	FCGR2A FCGR2B	8.35e-06	2	101	2	8824160
Pubmed	Regulation of allograft survival by inhibitory FcγRIIb signaling.	FCGR2A FCGR2B	8.35e-06	2	101	2	23150718
Pubmed	FcγRIIIA Negatively Impacts Humoral Immune Responses but Not Overall Lung Inflammation in an Ovalbumin-Induced Allergic Asthma Mouse Model.	FCGR2A FCGR2B	8.35e-06	2	101	2	29597194
Pubmed	Antibody-mediated coengagement of FcγRIIb and B cell receptor complex suppresses humoral immunity in systemic lupus erythematosus.	FCGR2A FCGR2B	8.35e-06	2	101	2	21357255
Pubmed	Association of FcγRIIB and FcγRIIA R131H gene polymorphisms with renal involvement in Egyptian systemic lupus erythematosus patients.	FCGR2A FCGR2B	8.35e-06	2	101	2	24366619
Pubmed	Differences in endocytosis mediated by FcγRIIA and FcγRIIB2.	FCGR2A FCGR2B	8.35e-06	2	101	2	21945020
Pubmed	Reversal of immune thrombocytopenia in mice by cross-linking human immunoglobulin G with a high-affinity monoclonal antibody.	FCGR2A FCGR2B	8.35e-06	2	101	2	16925577
Pubmed	FcγRIIb on liver sinusoidal endothelium clears small immune complexes.	FCGR2A FCGR2B	8.35e-06	2	101	2	23053513
Pubmed	A complementary DNA clone for a macrophage-lymphocyte Fc receptor.	FCGR2A FCGR2B	8.35e-06	2	101	2	3024012
Pubmed	Human rhinovirus type 2-antibody complexes enter and infect cells via Fc-gamma receptor IIB1.	FCGR2A FCGR2B	8.35e-06	2	101	2	14990693
Pubmed	Fcgamma receptor IIB-deficient mice develop Goodpasture's syndrome upon immunization with type IV collagen: a novel murine model for autoimmune glomerular basement membrane disease.	FCGR2A FCGR2B	8.35e-06	2	101	2	10704470
Pubmed	Biochemical characterization of murine lymphoid alloantigen Ly-m20.2, a cell surface marker controlled by a gene linked to the Mls locus.	FCGR2A FCGR2B	8.35e-06	2	101	2	3161943
Pubmed	Lipopolysaccharide Impedes Bone Repair in FcγRIIB-Deficient Mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	38069267
Pubmed	Autoimmune-prone mice share a promoter haplotype associated with reduced expression and function of the Fc receptor FcgammaRII.	FCGR2A FCGR2B	8.35e-06	2	101	2	10704418
Pubmed	Plasmodium curtails autoimmune nephritis via lasting bone marrow alterations, independent of hemozoin accumulation.	FCGR2A FCGR2B	8.35e-06	2	101	2	37539049
Pubmed	Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies.	FCGR2A FCGR2B	8.35e-06	2	101	2	23897982
Pubmed	CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.	FCGR2A FCGR2B	8.35e-06	2	101	2	16757681
Pubmed	FcγRIIb attenuates TLR4‑mediated NF‑κB signaling in B cells.	FCGR2A FCGR2B	8.35e-06	2	101	2	28849025
Pubmed	Fc receptor beta chain deficiency exacerbates murine arthritis in the anti-type II collagen antibody-induced experimental model.	FCGR2A FCGR2B	8.35e-06	2	101	2	23053716
Pubmed	Fc gamma RIIB regulates nasal and oral tolerance: a role for dendritic cells.	FCGR2A FCGR2B	8.35e-06	2	101	2	15843524
Pubmed	Lupus nephritis progression in FcγRIIB-/-yaa mice is associated with early development of glomerular electron dense deposits and loss of renal DNase I in severe disease.	FCGR2A FCGR2B	8.35e-06	2	101	2	29190833
Pubmed	Identification of a high affinity FcgammaRIIA-binding peptide that distinguishes FcgammaRIIA from FcgammaRIIB and exploits FcgammaRIIA-mediated phagocytosis and degradation.	FCGR2A FCGR2B	8.35e-06	2	101	2	18957413
Pubmed	Fcgamma receptor-dependent expansion of a hyperactive monocyte subset in lupus-prone mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	19644866
Pubmed	Comment on "The inhibiting Fc receptor for IgG, FcgammaRIIB, is a modifier of autoimmune susceptibility".	FCGR2A FCGR2B	8.35e-06	2	101	2	21969314
Pubmed	Immunoglobulin E plays an immunoregulatory role in lupus.	FCGR2A FCGR2B	8.35e-06	2	101	2	25267791
Pubmed	FcγRIIB regulates T-cell autoreactivity, ANCA production, and neutrophil activation to suppress anti-myeloperoxidase glomerulonephritis.	FCGR2A FCGR2B	8.35e-06	2	101	2	24869670
Pubmed	Lupus-Associated Immune Complexes Activate Human Neutrophils in an FcγRIIA-Dependent but TLR-Independent Response.	FCGR2A FCGR2B	8.35e-06	2	101	2	30610165
Pubmed	Fc receptors.	FCGR2A FCGR2B	8.35e-06	2	101	2	1910686
Pubmed	Susceptibility quantitative trait loci for pathogenic leucocytosis in SCG/Kj mice, a spontaneously occurring crescentic glomerulonephritis and vasculitis model.	FCGR2A FCGR2B	8.35e-06	2	101	2	24654803
Pubmed	An alloantigen selective for B cells: Ly-17.1.	FCGR2A FCGR2B	8.35e-06	2	101	2	6974691
Pubmed	Functional Role of FcγRIIB in the Regulation of Mesenchymal Stem Cell Function.	FCGR2A FCGR2B	8.35e-06	2	101	2	26941575
Pubmed	Differential role of three major New Zealand Black-derived loci linked with Yaa-induced murine lupus nephritis.	FCGR2A FCGR2B	8.35e-06	2	101	2	15634937
Pubmed	Genetically determined aberrant down-regulation of FcgammaRIIB1 in germinal center B cells associated with hyper-IgG and IgG autoantibodies in murine systemic lupus erythematosus.	FCGR2A FCGR2B	8.35e-06	2	101	2	10508186
Pubmed	Contribution of Fcγ receptors to human respiratory syncytial virus pathogenesis and the impairment of T-cell activation by dendritic cells.	FCGR2A FCGR2B	8.35e-06	2	101	2	26451966
Pubmed	Regulated expression of FcgammaR in human dendritic cells controls cross-presentation of antigen-antibody complexes.	FCGR2A FCGR2B	8.35e-06	2	101	2	17142741
Pubmed	Activatory and inhibitory Fcγ receptors augment rituximab-mediated internalization of CD20 independent of signaling via the cytoplasmic domain.	FCGR2A FCGR2B	8.35e-06	2	101	2	25568316
Pubmed	A lupus-suppressor BALB/c locus restricts IgG2 autoantibodies without altering intrinsic B cell-tolerance mechanisms.	FCGR2A FCGR2B	8.35e-06	2	101	2	18322187
Pubmed	Thymic stromal lymphopoietin transgenic mice develop cryoglobulinemia and hepatitis with similarities to human hepatitis C liver disease.	FCGR2A FCGR2B	8.35e-06	2	101	2	17322382
Pubmed	Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum.	FCGR2A FCGR2B	8.35e-06	2	101	2	8906852
Pubmed	A new mouse cell-surface antigen (Ly-m20) controlled by a gene linked to Mls locus and defined by monoclonal antibodies.	FCGR2A FCGR2B	8.35e-06	2	101	2	6173319
Pubmed	CD16/32-specific biotinylated 2.4G2 single-chain Fv complexed with avidin-FITC enhances FITC-specific humoral immune response in vivo in a CD16-dependent manner.	FCGR2A FCGR2B	8.35e-06	2	101	2	19951957
Pubmed	FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis.	FCGR2A FCGR2B	8.35e-06	2	101	2	26342897
Pubmed	FcgammaRIIb balances efficient pathogen clearance and the cytokine-mediated consequences of sepsis.	FCGR2A FCGR2B	8.35e-06	2	101	2	14981111
Pubmed	A serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibody requires Fcγ receptor III and macrophages to mediate protection against pneumococcal pneumonia in mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	22290146
Pubmed	Neutrophil responsiveness to IgG, as determined by fixed ratios of mRNA levels for activating and inhibitory FcgammaRII (CD32), is stable over time and unaffected by cytokines.	FCGR2A FCGR2B	8.35e-06	2	101	2	16551965
Pubmed	Analysis of a wild mouse promoter variant reveals a novel role for FcγRIIb in the control of the germinal center and autoimmunity.	FCGR2A FCGR2B	8.35e-06	2	101	2	23109709
Pubmed	Augmentation of pulmonary host defense against Pseudomonas by FcgammaRIIA cDNA transfer to the respiratory epithelium.	FCGR2A FCGR2B	8.35e-06	2	101	2	10449433
Pubmed	Spontaneous autoimmune disease in Fc(gamma)RIIB-deficient mice results from strain-specific epistasis.	FCGR2A FCGR2B	8.35e-06	2	101	2	10981970
Pubmed	Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo.	FCGR2A FCGR2B	8.35e-06	2	101	2	24505033
Pubmed	The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.	FCGR2A FCGR2B	8.35e-06	2	101	2	23411782
Pubmed	The impact of genetic susceptibility to systemic lupus erythematosus on placental malaria in mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	23675429
Pubmed	Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.	FCGR2A FCGR2B	8.35e-06	2	101	2	2529342
Pubmed	Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG.	FCGR2A FCGR2B	8.35e-06	2	101	2	10330436
Pubmed	Elk1 enhances inflammatory cell infiltration and exacerbates acute lung injury/acute respiratory distress syndrome by suppressing Fcgr2b transcription.	FCGR2A FCGR2B	8.35e-06	2	101	2	38649840
Pubmed	Polymorphism of Fc receptor on murine B cells is Igh-linked.	FCGR2A FCGR2B	8.35e-06	2	101	2	3159826
Pubmed	The pre-B cell receptor signaling for apoptosis is negatively regulated by Fc gamma RIIB.	FCGR2A FCGR2B	8.35e-06	2	101	2	11777955
Pubmed	Failed up-regulation of the inhibitory IgG Fc receptor Fc gamma RIIB on germinal center B cells in autoimmune-prone mice is not associated with deletion polymorphisms in the promoter region of the Fc gamma RIIB gene.	FCGR2A FCGR2B	8.35e-06	2	101	2	16034080
Pubmed	FcgammaRIIB regulates autoreactive primary antibody-forming cell, but not germinal center B cell, activity.	FCGR2A FCGR2B	8.35e-06	2	101	2	17202351
Pubmed	Immune complex enhances tolerogenecity of immature dendritic cells via FcγRIIb and promotes FcγRIIb-overexpressing dendritic cells to attenuate lupus.	FCGR2A FCGR2B	8.35e-06	2	101	2	21360699
Pubmed	The effect of FcγRIIA and FcγRIIB on coronary artery lesion formation and intravenous immunoglobulin treatment responses in children with Kawasaki disease.	FCGR2A FCGR2B	8.35e-06	2	101	2	27893416
Pubmed	Fc Gamma Receptor IIb Expressed in Hepatocytes Promotes Lipid Accumulation and Gluconeogenesis.	FCGR2A FCGR2B	8.35e-06	2	101	2	30261661
Pubmed	Fc gamma receptor IIb modulates the molecular Grb2 interaction network in activated B cells.	FCGR2A FCGR2B	8.35e-06	2	101	2	21262349
Pubmed	Dysregulation of Lipid Metabolism in Macrophages Is Responsible for Severe Endotoxin Tolerance in FcgRIIB-Deficient Lupus Mice.	FCGR2A FCGR2B	8.35e-06	2	101	2	32582149
Pubmed	Adenovirus-mediated Overexpression of FcγRIIB Attenuates Pulmonary Inflammation and Fibrosis.	FCGR2A FCGR2B	8.35e-06	2	101	2	36227848
Pubmed	Spatial raft coalescence represents an initial step in Fc gamma R signaling.	FCGR2A FCGR2B	8.35e-06	2	101	2	12077245
Pubmed	Ontogeny and distribution of the murine B cell Fc gamma RII.	FCGR2A FCGR2B	8.35e-06	2	101	2	1387140
Pubmed	Downmodulation of vaccine-induced immunity and protection against the intracellular bacterium Francisella tularensis by the inhibitory receptor FcγRIIB.	FCGR2A FCGR2B	8.35e-06	2	101	2	25961064
Pubmed	Identification of markers that distinguish IgE- from IgG-mediated anaphylaxis.	FCGR2A FCGR2B	8.35e-06	2	101	2	21746933
Interaction	NANOG interactions	ILF3 MAGED1 ZCCHC8 NBN ZMIZ1 TEX10 TRRAP ASH2L KMT2C CDK2AP1 G3BP2 ZFR	3.38e-06	481	97	12	int:NANOG
Cytoband	15q21	MYO5A SCG3	2.60e-04	11	101	2	15q21
Cytoband	Ensembl 112 genes in cytogenetic band chr15q21	MYO5A SCG3 CEP152 SLC27A2	6.52e-04	177	101	4	chr15q21
Cytoband	9q21.32	SPATA31D4 SPATA31D3	8.00e-04	19	101	2	9q21.32
Cytoband	1q23	FCGR2A FCGR2B	1.18e-03	23	101	2	1q23
Cytoband	Ensembl 112 genes in cytogenetic band chr1q23	NTRK1 FCGR2C FCGR2A FCGR2B	1.61e-03	226	101	4	chr1q23
Cytoband	14q32.33	IGHV1-45 IGHV1-8 IGHV1-3 IGHV1-2	1.66e-03	228	101	4	14q32.33
GeneFamily	Immunoglobulin like domain containing	MXRA5 NTRK1 MDGA2 FCGR2A PTPRM FCGR2B CNTN5	1.16e-05	193	72	7	594
GeneFamily	PHD finger proteins	MLLT10 KMT2E ASH2L KMT2C	4.56e-04	90	72	4	88
GeneFamily	CD molecules\|C-type lectin domain family\|Killer cell lectin like receptors	KLRG1 KLRD1	1.01e-03	12	72	2	621
Coexpression	P53_DN.V1_DN	MYO5A BCHE DDB2 PTPRM GLS NAV3 FGB MMP7	6.94e-07	194	98	8	M2697
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	NUP98 NBN SEMA5A ZMIZ1 LARP4 TRRAP USP6 ARHGAP12 PARD3 KPNA3	9.94e-06	466	98	10	M13522
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	NUP98 NBN SEMA5A ZMIZ1 LARP4 TRRAP USP6 ELL2 PTPRM ARHGAP12 NAV3 PARD3 KPNA3	1.82e-05	856	98	13	M4500
ToppCell	facs-MAT-Fat-3m-Lymphocytic-T_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	NABP1 DNAJC6 SPATA31D3 ELL2 KLRG1 TMEM64	3.06e-06	176	101	6	71b3309ddadd035a1224fca4fc5946dc4c0283fe
ToppCell	TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2\|TCGA-Skin / Sample_Type by Project: Shred V9	NEDD4L RASGRF1 LAMP2 DNAJC6 VANGL1 G3BP2	3.60e-06	181	101	6	9d5b331cabc5524f0a9fd8b571e87be4c447c7d4
ToppCell	COPD-Epithelial-ATI\|World / Disease state, Lineage and Cell class	NEDD4L GKN2 SEMA5A PTPN21 SHANK2 PARD3	3.72e-06	182	101	6	e95d946a43b1579af199900bb0e3eacbb9d65300
ToppCell	COPD-Epithelial-ATI\|COPD / Disease state, Lineage and Cell class	NEDD4L GKN2 SEMA5A PTPN21 SHANK2 PARD3	4.21e-06	186	101	6	df0977f6f48a2d4e11b59971f098b01204242f0f
ToppCell	severe-B_cell\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	BACH2 ELL2 PAXBP1 FCGR2B SLC27A2 SENP5	5.36e-06	194	101	6	2fee6083fb56b16d1f04fd0b92ec622fd26ba3fa
ToppCell	droplet-Liver-nan-3m-Epithelial-Hepatocyte_(Pericentral,_Midlobular,_Periportal)\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	BCHE APOB UROC1 FGB SLC27A2	2.43e-05	151	101	5	cc9632b58522e2ba3ad36a0b8d37c7c9c8b636c4
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-epithelial_cell_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A DNAJC6 FCGR2B TRIM62 MKI67	2.76e-05	155	101	5	0e24e767a3895d31d34cabeaca0354aadae34e44
ToppCell	facs-Large_Intestine-Distal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A DNAJC6 FCGR2B TRIM62 MKI67	2.76e-05	155	101	5	f3489a548a2c0cc2d9117ff85865c6089ea0835d
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM APOB UROC1 AQP1 SLC27A2	3.41e-05	162	101	5	de0fde4310a56dc96bfc134c44d104993526d9bc
ToppCell	PND10-Immune-Immune_Myeloid-DC-cDC2-cDC2_prolif\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYO5A ZRANB3 FCGR2B GLIPR2 CEP152	3.51e-05	163	101	5	7af3d3ae7e0de733a18d0486c7ffbb5a7ef7230a
ToppCell	PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	NABP1 MKI67 ELOVL6 KLRG1 KLRD1	3.62e-05	164	101	5	ae09e5aabd1347b865474255e7411c04f63efb3b
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A APOB AQP1 ELOVL6 SLC27A2	3.94e-05	167	101	5	ed7e785dcd25777f64e0c2596ada4f5a5ea17121
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM APOB UROC1 AQP1 SLC27A2	4.06e-05	168	101	5	b14fd50232887b6dca1f39014d43c6f66e5c3b5c
ToppCell	droplet-Kidney-nan-18m-Epithelial-brush_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO5A APOB AQP1 ELOVL6 SLC27A2	4.17e-05	169	101	5	f00741203efa0b948db7223ee8c19bdd0918258a
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	NEDD4L SEMA5A SHANK2 PTPRM PARD3	4.29e-05	170	101	5	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAM EYS ELL2 SCG3 SEZ6	4.54e-05	172	101	5	2651dece87c3e3d2d6370f5274ebae357474b825
ToppCell	5'-GW_trimst-2-SmallIntestine-Epithelial-neuro-epithelial-I_cells_(CCK+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MGAM ZPLD1 ELL2 SCG3 SEZ6	4.92e-05	175	101	5	c031da47ca63d1133e13530cbf779df9435e22cb
ToppCell	facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte-Alox5+_lymphocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NABP1 PAXBP1 SHANK2 GLIPR2 KLRG1	5.20e-05	177	101	5	b7cfa3776f58377e35830780650d236b5cceecee
ToppCell	facs-Lung-18m-Hematologic-Lymphocytic_NK_ILC-Alox5+_lymphocyte\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NABP1 PAXBP1 SHANK2 GLIPR2 KLRG1	5.20e-05	177	101	5	1730e640986e50943bd781b7d949bcc5b7c12dde
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SEMA5A GLS MMP7 PARD3 CTSV	5.34e-05	178	101	5	a0ab20c588e7d43d0320d4779d9ab95c1c86e297
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ARMC3 SEMA5A AQP1 PARD3 TMEM64	5.93e-05	182	101	5	5e1b316599436740f1b30875f0ebd33c3edfb2b6
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEDD4L RASGRF1 SHANK2 PARD3 TMEM64	6.09e-05	183	101	5	6847c1252d6bb105524f812658112517fd351eab
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	NABP1 FCGR2C ELL2 FCGBP GLS	6.09e-05	183	101	5	62f76907e501bba6e1010b5c447faed5f0ef93a7
ToppCell	facs-Liver-Non-hepatocytes-24m-Endothelial-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEMA5A AQP1 FCGR2B PLAT LRRC7	6.09e-05	183	101	5	ebe369dc80c4fbf8f4dbe947147f8c47507ffb60
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEDD4L SEMA5A PTPN21 SHANK2 PARD3	6.25e-05	184	101	5	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	NEDD4L SEMA5A PTPN21 SHANK2 PARD3	6.25e-05	184	101	5	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAGED1 SCG3 GLS FGB SLC27A2	6.41e-05	185	101	5	4e40d3103ebf4a7066b7ce300b6ef700ba0e2863
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	NEDD4L GKN2 SEMA5A PTPN21 PARD3	6.41e-05	185	101	5	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	Control-Epithelial-ATI\|Control / Disease state, Lineage and Cell class	NEDD4L SEMA5A PTPN21 SHANK2 PARD3	6.74e-05	187	101	5	fdd1c57b61ca9392ac27661a82729f37593df63c
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	NEDD4L NABP1 KLRG1 KLRD1 SENP5	6.74e-05	187	101	5	b426a67b5669019115b58295ce7d304beeb75825
ToppCell	Endothelial-B-IPF_03\|World / lung cells shred on cell class, cell subclass, sample id	NUP98 PTPN21 DNAJC6 VANGL1 LRRC7	6.91e-05	188	101	5	ecb74d67314a43b5805b7f2a7bb9ff6c5a60200a
ToppCell	AT1-AT2_cells-Donor_01\|World / lung cells shred on cell class, cell subclass, sample id	GKN2 SEMA5A PTPN21 PARD3 PCBP4	6.91e-05	188	101	5	be710bc957118cf426dd71c2d57e6f1b41c9a467
ToppCell	COPD-Multiplet-Multiplet\|World / Disease state, Lineage and Cell class	BACH2 SHANK2 MKI67 PARD3 KLRD1	6.91e-05	188	101	5	186fe1ea328c942910190a4240262c0d8642ea3b
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells-Erythrocyte\|World / Lineage, cell class and subclass	GKN2 DNAJC6 AQP1 MKI67 ELOVL6	7.09e-05	189	101	5	826457adac7477102f86aceb97a8b77929b3e6f9
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	NEDD4L SEMA5A PTPN21 SHANK2 PARD3	7.09e-05	189	101	5	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Control-Epithelial-ATII\|Control / Disease state, Lineage and Cell class	NEDD4L RASGRF1 GKN2 SHANK2 PARD3	7.27e-05	190	101	5	d50902a3abcc18aafa36d83cc2c6e07d7f7cb197
ToppCell	Megakaryocytic-erythropoietic-Erythro-cells\|World / Lineage, cell class and subclass	GKN2 DNAJC6 AQP1 MKI67 ELOVL6	7.27e-05	190	101	5	6c7e016a9b425ee9418acd4fe96b9779fe7bd39a
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-A\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAGED1 SEMA5A BCHE CDK2AP1 PLAT	7.27e-05	190	101	5	a28e14fff75c36b1a8634eaf3f305e3206fdc2ed
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	NEDD4L SEMA5A PTPN21 SHANK2 PARD3	7.27e-05	190	101	5	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	SEMA5A CDK2AP1 SCG3 PLAT CAMTA1	7.64e-05	192	101	5	1d0d6fb89a2b941b7caab2f1f07d6bd5433a11e7
ToppCell	human_hepatoblastoma-Tumor_cells\|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells)	NEDD4L ZRANB3 ELL2 SHANK2 PARD3	7.82e-05	193	101	5	503a979328c68b096680b71359a26f02fafdff35
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Dividing_Basal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ZNF391 GKN2 APOB MKI67 CTSV	8.02e-05	194	101	5	d790cfff3664e46fe2fd2f6b0c26896799927845
ToppCell	proximal-3-Hematologic-IGSF21+_Dendritic\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FCGR2C FCGR2A FCGR2B TRIM62 CEP152	8.21e-05	195	101	5	8592d0332bc82a91e173680cfd1afc5ee189b289
ToppCell	proximal-Hematologic-IGSF21+_Dendritic\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FCGR2C FCGR2A FCGR2B TRIM62 CEP152	8.21e-05	195	101	5	c48ff83c48342875f06c6c9e7d5bc6084a992848
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)\|renal_medulla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	AQP1 FCGBP CYCS FGB MMP7	8.21e-05	195	101	5	633c7668fe365f7b0f7851cdc442d5dd89c454e2
ToppCell	proximal-Hematologic-IGSF21+_Dendritic-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	FCGR2C FCGR2A FCGR2B TRIM62 CEP152	8.21e-05	195	101	5	ae9d61011e95f7840cbb154738c79745fd29943e
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L SHANK2 PTPRM PARD3 MBD5	8.41e-05	196	101	5	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	COPD-Multiplet-Multiplet\|COPD / Disease state, Lineage and Cell class	NEDD4L ARMC3 SHANK2 MKI67 PARD3	8.41e-05	196	101	5	af4cdc61830685a888a1209826c23bcf54a43084
ToppCell	COPD-Multiplet\|COPD / Disease state, Lineage and Cell class	NEDD4L ARMC3 SHANK2 MKI67 PARD3	8.41e-05	196	101	5	6d02d494196e3f857d53eea46d9419690d43beca
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MGAM FCGBP FCGR2A FCGR2B MKI67	8.62e-05	197	101	5	0a404b4494a2246d5a92299235056f0fda4d2b48
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	MGAM NBN NABP1 FCGR2A GLIPR2	8.62e-05	197	101	5	340ce4fef244176fb52e38ffbcbdfda5ac3467dd
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MAGED1 BCHE SCG3 PLAT SEZ6	8.83e-05	198	101	5	3550798bfb9a426f3b28538a9778159bec2480d0
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L SHANK2 PTPRM PARD3 MBD5	8.83e-05	198	101	5	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Epithelial\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SI APOB GLS FGB CTSV	8.83e-05	198	101	5	ecdef1a0a0b8399e193b922c8ca8c25e63de4a4f
ToppCell	Bronchus_Control_(B.)-Endothelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	SCG3 LRRC7 PARD3 PCBP4 CTSV	8.83e-05	198	101	5	feac39036b5c0ab97b524cc366286942d136d42f
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	NEDD4L RASGRF1 SHANK2 PTPRM PARD3	9.04e-05	199	101	5	725610310e5c5fd7120c0be9acb55bf152026ddd
ToppCell	3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	NEDD4L ARMC3 MORN2 SHANK2 MMP7	9.04e-05	199	101	5	92fdf6e2f0786ab2ab78126e9131a93794168139
ToppCell	ileum-Absorptive_Enterocytes\|ileum / shred on tissue and cell subclass	MGAM SI APOB	1.10e-04	41	101	3	650cec538c6acd92f45d804b3c94248c6231aa21
Drug	3,5-diaminocyclohexan-1-ol	NUP98 FCGR2C FCGR2A FCGR2B MKI67 LRRC7	3.89e-07	67	96	6	CID004632239
Drug	MDL 20,610	FCGR2C FCGR2A FCGR2B	7.22e-07	5	96	3	CID000128209
Drug	TAN-1030A	FCGR2C FCGR2A FCGR2B	1.44e-06	6	96	3	CID009576886
Drug	GR144053	MTOR FGB PLAT	2.51e-06	7	96	3	CID000173613
Drug	AC1MHTIN	FCGR2C FCGR2A FCGR2B	2.51e-06	7	96	3	CID003011133
Drug	TAN-999	FCGR2C FCGR2A FCGR2B	2.51e-06	7	96	3	CID000130283
Drug	rhamnose	MGAM NBN BCHE PTPRM FGB PLAT LRRC7 LTBP1 KLRG1 KLRD1	2.64e-06	356	96	10	CID000000840
Drug	sodiosodium	MGAM FCGR2C FCGR2A FCGR2B CNTN5	3.22e-06	54	96	5	CID000141233
Drug	Intravenous Immunoglobulin	FCGR2C FCGR2A FCGR2B	4.01e-06	8	96	3	DB00028
Drug	N-bromosuccinamide	NBN BCHE CYCS	5.99e-06	9	96	3	CID009834204
Drug	AC1NSK5W	FCGR2C FCGR2A FCGR2B	5.99e-06	9	96	3	CID005311182
Drug	Palivizumab	FCGR2C FCGR2A FCGR2B	8.53e-06	10	96	3	DB00110
Drug	Denny-Jaffe reagent	FCGR2C FCGR2A FCGR2B	8.53e-06	10	96	3	CID003035979
Drug	Bevacizumab	FCGR2C FCGR2A FCGR2B	1.17e-05	11	96	3	DB00112
Drug	Tositumomab	FCGR2C FCGR2A FCGR2B	1.17e-05	11	96	3	DB00081
Drug	Alemtuzumab	FCGR2C FCGR2A FCGR2B	1.17e-05	11	96	3	DB00087
Drug	Efalizumab	FCGR2C FCGR2A FCGR2B	1.17e-05	11	96	3	DB00095
Drug	Alefacept	FCGR2C FCGR2A FCGR2B	1.17e-05	11	96	3	DB00092
Drug	Daclizumab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00111
Drug	Natalizumab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00108
Drug	Rituximab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00073
Drug	Ibritumomab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00078
Drug	Adalimumab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00051
Drug	Gemtuzumab ozogamicin	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00056
Drug	Cetuximab	FCGR2C FCGR2A FCGR2B	1.55e-05	12	96	3	DB00002
Drug	iodide	NTRK1 NBN APOB FCGR2C FCGR2A FCGR2B CNTN5 CYCS FGB PLAT LRRC7	1.56e-05	534	96	11	CID000024841
Drug	AC1O1I4V	MGAM SHANK2	1.76e-05	2	96	2	CID000516923
Drug	Methylphenidate	NABP1 PTPN21 MORN2 FCGR2B MTOR LRRC27	1.80e-05	129	96	6	ctd:D008774
Drug	H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A	ILF3 NBN NABP1 PTPN21 MTOR ZFR LTBP1	1.84e-05	194	96	7	6921_UP
Drug	tungstopterin	NBN APOB DDB2 MTOR FGB PLAT	1.96e-05	131	96	6	CID005460240
Drug	acetochlor	APOB SHANK2 VANGL1 ELOVL6	1.96e-05	38	96	4	CID000001988
Drug	Trastuzumab	FCGR2C FCGR2A FCGR2B	2.01e-05	13	96	3	DB00072
Drug	Basiliximab	FCGR2C FCGR2A FCGR2B	2.01e-05	13	96	3	DB00074
Drug	Glucose	MGAM NTRK1 SI LAMP2 APOB AQP1 MTOR TRIM62 GLS CYCS MKI67 PLAT LTBP1 MMP7 ELOVL6 MBD5 TMEM64 KPNA3	2.38e-05	1420	96	18	ctd:D005947
Drug	Abciximab	FCGR2C FCGR2A FCGR2B	2.56e-05	14	96	3	DB00054
Drug	Etanercept	FCGR2C FCGR2A FCGR2B	2.56e-05	14	96	3	DB00005
Drug	Muromonab	FCGR2C FCGR2A FCGR2B	3.19e-05	15	96	3	DB00075
Drug	propham	NBN FCGR2C FCGR2B KLRG1	3.54e-05	44	96	4	CID000024685
Drug	AC1L9LSE	FCGR2C FCGR2A FCGR2B	3.91e-05	16	96	3	CID000448272
Drug	DL-1,2-anhydro-myo-inositol	MGAM SI BCHE TRRAP	4.23e-05	46	96	4	CID000002859
Drug	AC1Q5HK6	MGAM SI APOB FCGR2C FCGR2A FCGR2B CYCS FGB ZFR PLAT	5.05e-05	501	96	10	CID000003640
Drug	Copper silicide	MGAM SI	5.26e-05	3	96	2	CID006336988
Drug	NTCDA	MGAM CYCS	5.26e-05	3	96	2	CID000006678
Drug	dbdC	MGAM MKI67	5.26e-05	3	96	2	CID000072684
Drug	2cgx	FCGR2C FCGR2A FCGR2B	5.66e-05	18	96	3	CID001548380
Drug	R13-1	FCGR2C FCGR2A FCGR2B	6.70e-05	19	96	3	CID000009666
Drug	I0329	MGAM NBN SI	9.14e-05	21	96	3	CID000439668
Drug	Loestrin	FCGR2C FCGR2A FCGR2B	9.14e-05	21	96	3	CID000062925
Drug	iodine monochloride	NBN APOB FGB	9.14e-05	21	96	3	CID000024640
Drug	GW 4064	APOB UROC1 AQP1 ELL2 SHANK2 GLIPR2 PLAT LTBP1 MMP7	9.83e-05	438	96	9	ctd:C412815
Drug	Acarbose	MGAM SI	1.05e-04	4	96	2	DB00284
Drug	nimbidiol	MGAM SI	1.05e-04	4	96	2	ctd:C496111
Drug	CuATP	MGAM GLS	1.05e-04	4	96	2	CID000167769
Drug	K0 1	BCHE APOB	1.05e-04	4	96	2	CID001190625
Drug	sodium oxide (Na2O	MGAM MTOR	1.05e-04	4	96	2	CID000073971
Drug	AC1Q5JRE	FCGR2C FCGR2A FCGR2B	1.06e-04	22	96	3	CID000188349
Drug	monodansylcadaverine	NTRK1 LAMP2 MTOR CYCS FGB	1.08e-04	111	96	5	CID000004247
Drug	AC1NAE4O	NBN APOB FGB PLAT MMP7	1.28e-04	115	96	5	CID004475485
Drug	CH-4	MGAM NUP98 MLLT10 FCGR2A	1.29e-04	61	96	4	CID006433504
Drug	NA-1	FCGR2C FCGR2A FCGR2B CNTN5	1.37e-04	62	96	4	CID000446091
Drug	4-mercaptopyridine	NBN BCHE CYCS	1.38e-04	24	96	3	CID002723889
Drug	phthalocyanine	MGAM APOB CYCS	1.56e-04	25	96	3	CID000168374
Drug	Fenbufen [36330-85-5]; Down 200; 15.8uM; PC3; HT_HG-U133A	TOB2 BACH2 NBN NABP1 MLLT10 ZFR	1.60e-04	191	96	6	4279_DN
Drug	Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; PC3; HT_HG-U133A	SEMA5A NABP1 ZFR ELOVL6 PARD3 SLC27A2	1.64e-04	192	96	6	4267_DN
Drug	N-acetylhexosamine	MGAM NTRK1 BCHE FCGR2A PTPRM FGB LRRC7 KLRG1 KLRD1	1.72e-04	472	96	9	CID000000899
Drug	mopyridone	CYCS PLAT	1.74e-04	5	96	2	CID000134102
Drug	AC1L53LJ	MGAM SI	1.74e-04	5	96	2	CID000197521
Drug	anthroylouabain	MGAM BCHE	1.74e-04	5	96	2	CID000124910
Drug	AC1O5T5C	CYCS PLAT	1.74e-04	5	96	2	CID006440182
Drug	dimethyl 2,3,5,6-tetrachloroterephthalate	ILF3 PCBP4	1.74e-04	5	96	2	ctd:C007220
Drug	6,6'-dimethyl-2,2'-bipyridine	CYCS PLAT	1.74e-04	5	96	2	CID000020445
Drug	AC1MIIGV	BCHE CYCS	1.74e-04	5	96	2	CID003045257
Drug	banol	BCHE CYCS	1.74e-04	5	96	2	CID000012636
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	ILF3 TBC1D22B MLLT10 ZFR LTBP1 ELOVL6	1.79e-04	195	96	6	4508_DN
Drug	Apramycin [37321-09-8]; Down 200; 7.4uM; PC3; HT_HG-U133A	TRRAP HDAC7 TRIM62 GLS MKI67 NAV3	1.79e-04	195	96	6	6614_DN
Drug	Ethisterone [434-03-7]; Down 200; 12.8uM; MCF7; HT_HG-U133A	TOB2 GLS ZFR LTBP1 ELOVL6 SENP5	1.79e-04	195	96	6	3864_DN
Drug	Oxantel pamoate [68813-55-8]; Up 200; 6.6uM; MCF7; HT_HG-U133A	PTPN21 PTPRM TRIM62 CEP152 PARD3 CTSV	1.84e-04	196	96	6	5338_UP
Drug	Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; HL60; HG-U133A	TOB2 MYO5A ZCCHC8 NBN ZFR PARD3	2.00e-04	199	96	6	1391_DN
Drug	Moricizine hydrochloride [31883-05-3]; Up 200; 8.6uM; PC3; HT_HG-U133A	BACH2 TBC1D22B NABP1 PTPN21 G3BP2 KLRG1	2.00e-04	199	96	6	7297_UP
Drug	Nalidixic acid sodium salt hydrate; Up 200; 14.6uM; MCF7; HT_HG-U133A	MXRA5 RASGRF1 AQP1 GLS KLRD1 SENP5	2.00e-04	199	96	6	2297_UP
Drug	cortisone 21-acetate	BCHE FCGR2C FCGR2A FCGR2B	2.20e-04	70	96	4	CID000002863
Drug	selenide	MGAM NBN SI	2.20e-04	28	96	3	CID000000533
Drug	3alpha, 7beta-dihydroxy-5beta-cholan-24-oic acid	SEMA5A FCGR2C FCGR2A FCGR2B CYCS SLC27A2	2.40e-04	206	96	6	CID000005645
Drug	alprostadil alfadex	MGAM PLAT	2.61e-04	6	96	2	CID005282234
Drug	Undecylmaltoside	MGAM CYCS	2.61e-04	6	96	2	CID000447793
Drug	triethylphosphorothioate	BCHE CYCS	2.61e-04	6	96	2	CID000031354
Drug	Rgdy	FGB PLAT	2.61e-04	6	96	2	CID000129979
Drug	AC1OCFTL	MGAM SI	2.61e-04	6	96	2	CID006918743
Drug	SCH 48461	MGAM APOB	2.61e-04	6	96	2	CID000132832
Drug	Thromstop	SI APOB FGB PLAT	2.72e-04	74	96	4	CID000004406
Drug	Androgen Antagonists	NTRK1 MDGA2 SHANK2 GLS	2.87e-04	75	96	4	ctd:D000726
Disease	malaria (implicated_via_orthology)	FCGR2C FCGR2A FCGR2B	2.59e-06	9	94	3	DOID:12365 (implicated_via_orthology)
Disease	Lower Extremity Paresis	BCHE PLAT	1.00e-05	2	94	2	C0751410
Disease	Upper Extremity Paresis	BCHE PLAT	1.00e-05	2	94	2	C0751409
Disease	Paresis	BCHE PLAT	1.00e-05	2	94	2	C0030552
Disease	Abnormality of the urinary system	ZMIZ1 TRRAP	1.00e-05	2	94	2	C4021821
Disease	Monoparesis	BCHE PLAT	1.00e-05	2	94	2	C0270795
Disease	prostate carcinoma (implicated_via_orthology)	MKI67 MMP7	1.00e-05	2	94	2	DOID:10286 (implicated_via_orthology)
Disease	Hemiparesis	BCHE PLAT	1.00e-05	2	94	2	C0018989
Disease	low affinity immunoglobulin gamma Fc region receptor II-a measurement	FCGR2C FCGR2A FCGR2B	2.06e-05	17	94	3	EFO_0021969
Disease	low affinity immunoglobulin gamma Fc region receptor II-b measurement	FCGR2C FCGR2A FCGR2B	6.84e-05	25	94	3	EFO_0021970
Disease	Intellectual Disability	ZCCHC8 UROC1 ZMIZ1 KMT2E TRRAP KMT2C SHANK2 MTOR	9.30e-05	447	94	8	C3714756
Disease	interstitial cystitis (is_marker_for)	MTOR MKI67	9.98e-05	5	94	2	DOID:13949 (is_marker_for)
Disease	tri-iodothyronine/thyroxine ratio measurement	ZMIZ1 KPNA3	9.98e-05	5	94	2	EFO_0009779
Disease	Neurotoxicity Syndromes	BCHE MTOR PLAT	1.08e-04	29	94	3	C0235032
Disease	Encephalopathy, Toxic	BCHE MTOR PLAT	1.08e-04	29	94	3	C0149504
Disease	Toxic Encephalitis	BCHE MTOR PLAT	1.08e-04	29	94	3	C0154659
Disease	FEV/FEC ratio	MGAM BACH2 BCHE FCGR2C FCGBP FCGR2A PTPRM FCGR2B CNTN5 ARHGAP12 LTBP1 PARD3 KPNA3	1.39e-04	1228	94	13	EFO_0004713
Disease	SYSTEMIC LUPUS ERYTHEMATOSUS	FCGR2A FCGR2B	1.49e-04	6	94	2	152700
Disease	crescentic glomerulonephritis (implicated_via_orthology)	FCGR2A MTOR	1.49e-04	6	94	2	DOID:13139 (implicated_via_orthology)
Disease	acute promyelocytic leukemia (is_marker_for)	KMT2E PLAT	1.49e-04	6	94	2	DOID:0060318 (is_marker_for)
Disease	low affinity immunoglobulin gamma Fc region receptor II-a/b measurement	FCGR2A FCGR2B	2.09e-04	7	94	2	EFO_0008211
Disease	lymphoid leukemia (is_implicated_in)	FCGR2A FCGR2B	2.09e-04	7	94	2	DOID:1037 (is_implicated_in)
Disease	disease recurrence, malaria	UROC1 PTPRM	2.78e-04	8	94	2	EFO_0001068, EFO_0004952
Disease	NEURAL TUBE DEFECTS, SUSCEPTIBILITY TO	VANGL1 PARD3	2.78e-04	8	94	2	C3891448
Disease	coronary artery disease (is_implicated_in)	BCHE APOB FCGR2A FGB	3.00e-04	100	94	4	DOID:3393 (is_implicated_in)
Disease	systemic lupus erythematosus (implicated_via_orthology)	FCGR2C FCGR2A FCGR2B	3.52e-04	43	94	3	DOID:9074 (implicated_via_orthology)
Disease	suicide behaviour measurement	PTPN21 CNTN5 MKI67	3.52e-04	43	94	3	EFO_0006882
Disease	plexin-B2 measurement	FCGR2C FCGR2B	3.56e-04	9	94	2	EFO_0021867
Disease	R-6-hydroxywarfarin to R-warfarin ratio measurement	ZPLD1 EYS PTPRM CNTN5	3.74e-04	106	94	4	EFO_0803333
Disease	carbohydrate measurement	EYS PTPRM ELOVL6	4.30e-04	46	94	3	EFO_0004998
Disease	hemolysis	AQP1 EYS CNTN5	4.59e-04	47	94	3	EFO_0009473
Disease	Celiac Disease	BACH2 APOB ZMIZ1	4.59e-04	47	94	3	C0007570
Disease	interleukin-6 measurement	BACH2 EFCAB13 MDGA2 KMT2E	4.61e-04	112	94	4	EFO_0004810
Disease	cytochrome p450 3a4 measurement	BCHE APOB	5.42e-04	11	94	2	EFO_0020303
Disease	Systemic lupus erythematosus	FCGR2A FCGR2B	5.42e-04	11	94	2	cv:C0024141
Disease	factor VIII deficiency (is_implicated_in)	FCGR2A PLAT	5.42e-04	11	94	2	DOID:12134 (is_implicated_in)
Disease	Malignant neoplasm of breast	EFCAB13 NUP98 DNAJC21 NBN BCHE ZMIZ1 HDAC7 MTOR G3BP2 MKI67 LRRC7	6.18e-04	1074	94	11	C0006142
Disease	integral membrane protein 2B measurement	BCHE APOB	6.49e-04	12	94	2	EFO_0802634
Disease	Acute Myeloid Leukemia, M1	BACH2 NUP98 MLLT10 KMT2C	6.97e-04	125	94	4	C0026998
Disease	Acute Myeloid Leukemia (AML-M2)	BACH2 NUP98 MLLT10 KMT2C	6.97e-04	125	94	4	C1879321
Disease	Sarcomatoid Renal Cell Carcinoma	BCHE MLLT10 MTOR NAV3	7.62e-04	128	94	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	BCHE MLLT10 MTOR NAV3	7.62e-04	128	94	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	BCHE MLLT10 MTOR NAV3	7.62e-04	128	94	4	C1266044
Disease	Papillary Renal Cell Carcinoma	BCHE MLLT10 MTOR NAV3	7.62e-04	128	94	4	C1306837
Disease	Renal Cell Carcinoma	BCHE MLLT10 MTOR NAV3	7.62e-04	128	94	4	C0007134
Disease	autoimmune thrombocytopenic purpura (is_marker_for)	FCGR2A PLAT	7.65e-04	13	94	2	DOID:8924 (is_marker_for)
Disease	systemic lupus erythematosus	ILF3 ARMC3 BACH2 FCGR2C FCGR2A FCGR2B GLS CYCS PLAT	1.02e-03	799	94	9	MONDO_0007915
Disease	acute graft vs. host disease, donor genotype effect measurement	MDGA2 EYS	1.03e-03	15	94	2	EFO_0004599, EFO_0007892
Disease	autoimmune thrombocytopenic purpura (is_implicated_in)	FCGR2A FCGR2B	1.03e-03	15	94	2	DOID:8924 (is_implicated_in)
Disease	brain edema (biomarker_via_orthology)	AQP1 PLAT	1.03e-03	15	94	2	DOID:4724 (biomarker_via_orthology)
Disease	Hypertriglyceridemia	BCHE APOB	1.03e-03	15	94	2	C0020557
Disease	thrombosis (is_implicated_in)	FCGR2A FGB	1.03e-03	15	94	2	DOID:0060903 (is_implicated_in)
Disease	Malaria, susceptibility to	FCGR2A FCGR2B	1.17e-03	16	94	2	cv:C1970028
Disease	–	FCGR2A FCGR2B	1.17e-03	16	94	2	611162
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	BCHE MLLT10 MTOR NAV3	1.31e-03	148	94	4	C0279702
Disease	Vitiligo	TOB2 BACH2	1.32e-03	17	94	2	C0042900
Disease	neutrophil count	ARMC3 ZNF391 NTRK1 BACH2 ZMIZ1 NABP1 KMT2E ZRANB3 FCGR2B VANGL1 FGB GNAT3	1.46e-03	1382	94	12	EFO_0004833
Disease	androstenedione measurement, estrone measurement	ARMC3 PTPRM	1.49e-03	18	94	2	EFO_0007970, EFO_0007972
Disease	C-reactive protein measurement	TOB2 ZPLD1 APOB ZNF226 ZMIZ1 MLLT10 DNAJC6 DDB2 CDK2AP1 SCG3 CAMTA1	1.58e-03	1206	94	11	EFO_0004458
Disease	acetone measurement	CDK2AP1 FCGR2B	1.66e-03	19	94	2	EFO_0010989
Disease	sodium-coupled monocarboxylate transporter 1 measurement	BCHE APOB	1.66e-03	19	94	2	EFO_0802076
Disease	Malaria	FCGR2A FCGR2B	1.84e-03	20	94	2	C0024530
Disease	gut microbiome measurement, bone density	FCGR2C PTPRM FCGR2B	2.00e-03	78	94	3	EFO_0003923, EFO_0007874
Disease	Neutropenia	NUP98 FCGR2B	2.03e-03	21	94	2	C0027947
Disease	status epilepticus (implicated_via_orthology)	MTOR PLAT	2.03e-03	21	94	2	DOID:1824 (implicated_via_orthology)
Disease	type 2 diabetes mellitus (is_implicated_in)	BCHE APOB MTOR PLAT	2.21e-03	171	94	4	DOID:9352 (is_implicated_in)
Disease	Leukemia, Myelocytic, Acute	BACH2 NUP98 MLLT10 KMT2C	2.31e-03	173	94	4	C0023467
Disease	Ovarian Serous Adenocarcinoma	NTRK1 TRRAP	2.43e-03	23	94	2	C1335177
Disease	malaria (is_implicated_in)	FCGR2A FCGR2B	2.65e-03	24	94	2	DOID:12365 (is_implicated_in)
Disease	nephrotic syndrome (biomarker_via_orthology)	APOB CTSV	2.65e-03	24	94	2	DOID:1184 (biomarker_via_orthology)
Disease	systemic mastocytosis	EYS NAV3	2.87e-03	25	94	2	MONDO_0016586
Disease	myeloid white cell count	NTRK1 BACH2 NABP1 KMT2E HDAC7 FCGR2A FCGR2B CNTN5 ELOVL6	3.02e-03	937	94	9	EFO_0007988
Disease	ankylosing spondylitis	BACH2 ZMIZ1 FCGR2A	3.11e-03	91	94	3	EFO_0003898

Protein segments in the cluster

Peptide	Gene	Start	Entry
VYNVDGPSNNATGQS	VANGL1	311	Q8TAA9
NYGQPHVGQKEVSNF	BACH2	391	Q9BYV9
QGNTASQGKEGPYSE	AKAP2	406	Q9Y2D5
NFAKYGNPNETQNNS	BCHE	501	P06276
KPYQSSAQNNGSPAQ	CEP152	196	O94986
DCFLNNPKQGQTYGG	CAMTA1	486	Q9Y6Y1
FNFYLSNVGKDNPQG	ELL2	81	O00472
VVGYGFEGANSNNSK	CTSV	281	O60911
TQPSYRFKANNNDSG	FCGR2A	86	P12318
QPSYRFKANNNDSGE	FCGR2B	96	P31994
SALGFKYPVGNNQTA	AQP1	31	P29972
NSGSKDFFNNQGIPQ	ARMC3	346	Q5W041
LSNIGPAYDNQKQSS	ASH2L	261	Q9UBL3
VGVYNNKGDGPFSQI	CNTN5	851	O94779
YTPQGDSDNGKENQT	GLS	646	O94925
NQGFSVQGQYGAVTP	PCBP4	196	P57723
KEIQGNSTFPNNFGF	PCDHB13	781	Q9Y5F0
NGNYTLLAANPFGQA	NTRK1	356	P04629
NNAFAQNKPTGFGNF	NUP98	106	P52948
TQGGTYNFDPTANLQ	KPNA3	501	O00505
YGNGDPQNFKLSQDD	MMP7	236	P09237
TGPNTFEDAGNYIKN	GNAT3	291	A8MTJ3
NFGPGFVNDSQRKQY	KMT2C	3166	Q8NEZ4
QNATTKGPNGVYDFS	MAGED1	81	Q9Y5V3
GTILYSNGNNCGKQF	EYS	2186	Q5T1H1
KVYQFDQSFNPQGSV	LRRC7	1026	Q96NW7
TPFNGNTNYAQKFQD	IGHV1-45	71	A0A0A0MS14
PFSRNHNGQGYKDQD	MGAM	681	O43451
NPNSGNTGYAQKFQG	IGHV1-8	71	P0DP01
QPSYRFKANNNDSGE	FCGR2C	96	P31995
QGFGNVATNTDGKNY	FGB	301	P02675
TKEAQPGQSQVSYQG	LTBP1	511	Q14766
NYANGNEKDSSKGPQ	NAV3	286	Q8IVL0
INENYNPKFFGNLQS	FAM214A	661	Q32MH5
QPSANFQNYNQLKGS	KMT2E	1561	Q8IZD2
EKPEAGTYSVNNGND	LAMP2	216	P13473
GGNVFFSAQNAAKQP	MKI67	806	P46013
NGYPSVVNAENKNTQ	PAXBP1	716	Q9Y5B6
GLKFNPLNTNQFYAS	DDB2	161	Q92466
QKPAQNYDDNFNVNG	DNAJC21	391	Q5F1R6
NPNSGGTNYAQKFQG	IGHV1-2	71	P23083
NAGNGNTKYSQKFQG	IGHV1-3	71	A0A0C4DH29
GTYSCIANNNVGNPA	MDGA2	306	Q7Z553
QTSQYNGFNVKPREA	MDGA2	516	Q7Z553
DANQNFGPSYNQGQT	ARHGAP12	131	Q8IWW6
ASSQDNLFVPNQNGY	PTPN21	356	Q16825
QSVCDQGFYNGPVSK	ELOVL6	96	Q9H5J4
GKLPQQANDYLNSFN	APOB	2116	P04114
YEVFNIISPSNNGGN	GKN2	21	Q86XP6
TQAQNDYGPQQKSSS	KLRG1	16	Q96E93
TGQAPGYSYTAANKN	CYCS	41	P99999
EIKNYNFQQPGFTSG	GLIPR2	86	Q9H4G4
FQKPNGSQAGNANEF	FCGBP	1401	Q9Y6R7
DASGKPQEAVYGQND	G3BP2	46	Q9UN86
QKPSYGSGYQSHQGQ	ILF3	741	Q12906
NYNVSFSAMPGGQNE	DNAJC6	751	O75061
QGTGNSQVPQSKYAE	CDK2AP1	51	O14519
SNVGVQEPYSKNGIN	EFCAB13	376	Q8IY85
SFVNGFNSPGSYKTN	LARP4	346	Q71RC2
YNGDFNAKSVNGCVP	MBD5	1336	Q9P267
GNGTQQTFYQDPSVL	HDAC7	711	Q8WUI4
QAAQPFTIGDNKTYN	PTPRM	671	P28827
QPGNNYSQDQGKFIS	OR2B8P	261	P59922
FYALGAKGQGQSQEQ	PCARE	626	A6NGG8
EQNYSPGEGFQSAKE	PARD3	1241	Q8TEW0
GPQTLKETSFNQAYG	MTOR	2061	P42345
NFSEPNPDYRGQQNK	NABP1	111	Q96AH0
NPDYRGQQNKGAQSE	NABP1	116	Q96AH0
GIQDNYTFAQPGIQK	TBC1D22B	361	Q9NU19
PQNTFFNTKYGESGN	LRRC27	511	Q9C0I9
NPSGINDDYGQLKNF	NBN	671	O60934
QLTPFNGYAGAKAQT	SLC27A2	431	O14975
VGNYQGCSQETAPKN	SPATA31D4	766	Q6ZUB0
TLTYNGNKNSLPFNE	SI	1786	P14410
KNSSEFPLFSYNNGV	RASGRF1	871	Q13972
VYGTIKPAFNQNSAA	SHANK2	916	Q9UPX8
AIAQAFSGPFKYQEN	SEMA5A	326	Q13591
NGIYNSNDVAVSFPN	MLLT10	566	P55197
TFPNGAKYTGNFNEN	MORN2	31	Q502X0
VGNYQGCSQETAPKN	SPATA31D3	766	P0C874
LVKGNQPNTSGSSFY	TMEM64	351	Q6YI46
QAVDSGQKPYSNLGQ	ZNF132	211	P52740
DGPVSQKAVQNENSY	SENP5	426	Q96HI0
FYRGNGKNQVEQSPQ	TRAV10	16	A0A0B4J240
NYLTSNFQAPGVKSG	ZCCHC8	401	Q6NZY4
PGSAQFNGYNCDANL	ZPLD1	16	Q8TCW7
GKVYTAQNPSAQALG	PLAT	246	P00750
AQFPQELVTYGGNGQ	UROC1	116	Q96N76
VYENGGSQPNVSSQF	TEX10	281	Q9NXF1
QFQSDPGTSVLGYQQ	SEZ6	681	Q53EL9
ENYIVNKADGPNNTG	ZNF226	146	Q9NYT6
YQTAPKAGYSQGATQ	ZFR	186	Q96KR1
SQTGEIQGQNKYFQG	RPTN	586	Q6XPR3
SYFSPGQSHANGKNV	TRIM62	451	Q9BVG3
NYEKATNANPSQLFG	TRRAP	2256	Q9Y4A5
SQLSPNAKEFVYNGG	TOB2	251	Q14106
ENKPGQSNYSFVDNL	SCG3	61	Q8WXD2
KYAPKFDGFQQQDSQ	USP6	611	P35125
SQPSFGQSFEYSKNG	ZNF248	206	Q8NDW4
FAGQQQQFSAKAGPA	ZMIZ1	216	Q9ULJ6
KPEQFNGQNNTFSGS	ZMIZ1	471	Q9ULJ6
TSKGYLQAVDNEGNP	ZRANB3	896	Q5FWF4
GNTAQGPTNEEDYKN	ZNF391	6	Q9UJN7
TFNTKNCIAYNPNGN	KLRD1	146	Q13241
NGYSKVFGNNNIPEA	MXRA5	1696	Q9NR99
NADNFNYTKQGGSPV	MYO5A	281	Q9Y4I1
NFGQTYQVDLKPNGS	NEDD4L	781	Q96PU5